FDA approves Coloplast's next-generation PU penile implant

The approval marks the commercial launch of the company's next-generation implant platform, which builds on the established Titan product line and incorporates a series of design improvements aimed at enhancing patient comfort, durability and ease of use. The device will be introduced through a phased US launch beginning later this year.

For the polyurethane industry, the development highlights the continuing importance of advanced medical-grade polyurethane elastomers in long-term implantable devices.

At the heart of the Titan system are inflatable cylinders manufactured from Coloplast's proprietary Bioflex material, a polyurethane elastomer designed to combine high strength, flexibility and fatigue resistance. The material has become a key differentiator for the Titan range, particularly in applications requiring repeated inflation and deflation cycles over many years of use.

According to Coloplast, Titan Prime introduces redesigned cylinders intended to provide a more natural appearance when deflated while maintaining the rigidity and girth associated with earlier Titan devices. The company has also upgraded the pump mechanism, which now requires around 50% less force to activate and incorporates a larger deflation button to improve usability.

The company said the implant's kink-resistant tubing is 11 times more resistant to abrasion failure than the tubing used in the previous generation device.

"We are excited to offer Titan Prime IPP, a clinically proven solution that helps men suffering from severe erectile dysfunction take back control of their intimate lives and relationships," said Kevin Hardage, president of Coloplast Interventional Urology.

"This FDA approval advances prosthetic urology and marks an important milestone for patients seeking long-term restoration of erectile function, as well as for clinicians committed to delivering the highest standard of care."

Inflatable penile prostheses represent one of the most demanding applications for implantable polymers. The materials must withstand thousands of inflation cycles while remaining biocompatible, resistant to tearing and capable of maintaining pressure over extended periods.

Coloplast's long-standing use of polyurethane contrasts with some competing devices that rely primarily on silicone-based constructions. Industry observers have often cited the higher tensile strength and resistance to aneurysmal expansion offered by polyurethane elastomers as advantages in applications where mechanical durability is critical.

The FDA approval follows a long history of regulatory clearances for the Titan platform. According to FDA records, the original Titan inflatable penile prosthesis has undergone multiple approved design enhancements over the years, including pump and reservoir improvements.

Around 30 million men in the US alone are estimated to experience ongoing erectile dysfunction, making inflatable prostheses an important treatment option when medication and less invasive therapies prove ineffective.

Coloplast